These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8973588)

  • 1. In vivo cisplatin resistance of rat ascites hepatoma AH66.
    Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
    Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
    Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
    Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cisplatin resistance depending upon canalicular multispecific organic anion transporter (cMOAT).
    Minamino T; Tamai M; Itoh Y; Tatsumi Y; Nomura M; Yokogawa K; Suzuki H; Sugiyama Y; Ohshima T; Miyamoto K
    Jpn J Cancer Res; 1999 Oct; 90(10):1171-8. PubMed ID: 10595747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
    Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
    Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
    Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
    Wakusawa S; Nakamura S; Inoko K; Miyamoto K
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
    Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly malignant rat hepatoma AH66F cells respond to ascitic fluid.
    Nomura M; Sugiura N; Yamamoto H; Miyamoto K
    Anticancer Res; 1997; 17(1A):209-14. PubMed ID: 9066653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M
    Cancer Lett; 1994 Apr; 78(1-3):77-83. PubMed ID: 7910111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin inhibits the Gs-stimulated adenylate cyclase in rat ascites hepatoma AH66F cells.
    Miyamoto K; Sanae F; Koshiura R; Matsunaga T; Hasegawa T; Takagi K; Satake T
    Exp Cell Res; 1989 Sep; 184(1):219-27. PubMed ID: 2551705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on the combined cytotoxic effect of forskolin with mitomycin C and responsiveness to forskolin in rat ascites hepatoma AH66 cells and AH66F cells.
    Miyamoto K; Matsunaga T; Koshiura R; Takagi K; Satake T; Hasegawa T
    J Pharmacobiodyn; 1987 Jul; 10(7):346-52. PubMed ID: 2826750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
    Wakusawa S; Miyamoto K; Koshiura R
    Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
    Wakusawa S; Takeda K; Miyamoto K; Hidaka H
    Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of natural resistance to vincristine in rat ascites hepatoma AH66.
    Inaba M; Takayama K; Sakurai Y
    Gan; 1981 Aug; 72(4):562-8. PubMed ID: 7308668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the metastatic ability of rat hepatoma cells in chick embryos by the polymerase-chain reaction.
    Yamamoto H; Endo Y; Nomura M; Miyamoto K; Sasaki T
    Anticancer Res; 1996; 16(1):413-7. PubMed ID: 8615646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse relationship between malignancy and cyclic AMP-dependent protein kinase activity in Yoshida rat ascites hepatomas.
    Miyamoto K; Nakamura S; Nomura M; Yamamoto H; Sanae F; Hidaka H
    Cancer Lett; 1993 Aug; 72(3):179-82. PubMed ID: 8402589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
    Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
    Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
    Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
    Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of horse anti-rat AFP antiserum on the uptake of 2-deoxy-D-glucose by AFP-producing rat hepatoma cells.
    Ohkawa K; Tsukada Y; Hibi N; Hirai H
    Int J Cancer; 1984 Apr; 33(4):497-502. PubMed ID: 6200448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.